G. Yao

Anchorage-independent cell growth signature identifies tumors with metastatic potential

Jeffrey T. Chang, Michael L. Gatza, J. Nevins, 2009, Oncogene.

Telomerase inhibition strategies by siRNAs against either hTR or hTERT in oral squamous cell carcinoma

G. Yao, M. Li, Y. Feng, 2011, Cancer Gene Therapy.

MOB2 suppresses GBM cell migration and invasion via regulation of FAK/Akt and cAMP/PKA signaling

Dapeng Liang, Songshu Meng, Jia Liu, 2020, Cell Death & Disease.

Inhibition of telomerase RNA (hTR) in cervical cancer by adenovirus-delivered siRNA

G. Yao, H. Li, M. Li, 2007, Cancer Gene Therapy.

LASS2 enhances chemosensitivity of breast cancer by counteracting acidic tumor microenvironment through inhibiting activity of V-ATPase proton pump

G. Yao, Y. Wang, J. Gu, 2013, Oncogene.

Recombinant oncolytic Newcastle disease virus displays antitumor activities in anaplastic thyroid cancer cells

Quentin Liu, Wei Cheng, Songshu Meng, 2018, BMC Cancer.

c‐Myc–IMPDH1/2 axis promotes tumourigenesis by regulating GTP metabolic reprogramming

G. Yao, Xiaoya Yang, Jing Yu, 2023, Clinical and translational medicine.

Ajuba inhibits hepatocellular carcinoma cell growth via targeting of β-catenin and YAP signaling and is regulated by E3 ligase Hakai through neddylation

Dapeng Liang, Songshu Meng, G. Yao, 2018, Journal of experimental & clinical cancer research : CR.